Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.
about
Immune Infiltration and Prostate CancerImmunosuppression associated with chronic inflammation in the tumor microenvironmentMyeloid-derived suppressor cells in the tumor microenvironment: expect the unexpectedTumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesThe neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.Fundamental Principles of Cancer Biology: Does it have relevance to the perioperative period?Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer.Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotypeTargeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.Monocytes promote liver carcinogenesis in an oncogene-specific manner.Neutrophils: Critical components in experimental animal models of cancer.In Vitro and in Vivo Mechanism of Bone Tumor Inhibition by Selenium-Doped Bone Mineral Nanoparticles.Identification and characterization of CD133+CD44+ cancer stem cells from human laryngeal squamous cell carcinoma cell lines.In Vivo Imaging Sheds Light on Immune Cell Migration and Function in Cancer.Prognostic Biomarkers for Hodgkin Lymphoma.Senescence and cancer: An evolving inflammatory paradox.The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein.Melanocytic nevi and melanoma: unraveling a complex relationship.Drug discovery in advanced prostate cancer: translating biology into therapy.Pharmacological Modulation of Proton Channel Hv1 in Cancer Therapy: Future Perspectives.Neutrophils in cancer: neutral no more.Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cytokine and angiogenic factor signalling.The role of myeloid cells in cancer therapies.To clear, or not to clear (senescent cells)? That is the question.Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.Neutrophils in cancer.Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth.In Brief: Myeloid-derived suppressor cells in cancer.Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use.Tumor-associated myeloid cells as guiding forces of cancer cell stemness.Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines.Enhancing chemotherapy efficacy by reprogramming the senescence-associated secretory phenotype of prostate tumors: A way to reactivate the antitumor immunity.Myeloid-Derived Suppressor Cells.Effective combinatorial immunotherapy for castration-resistant prostate cancerOpposing activities of oncogenic MIR17HG and tumor suppressive MIR100HG clusters and their gene targets regulate replicative senescence in human adult stem cells.Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia.Tumor-infiltrating myeloid cells drive senescence evasion and chemoresistance in tumors.The potential of targeting Sin3B and its associated complexes for cancer therapy.
P2860
Q26798412-A0434A6B-3CF1-49FD-902A-D371795ADBC0Q28083450-9B985881-D355-42C6-A2A7-900711C03215Q28084627-136B6365-F550-407A-BA45-43F1629711BEQ34044797-7CFB91DB-7CF2-4089-9D49-B8A46AF4726AQ35274955-A2243C7B-4052-468A-B9E7-9AC52872FD0CQ36062109-A7319F2D-8B46-4EE5-A958-45F27448A0B1Q36081801-7B2BB419-7FDE-4849-BDCD-F83753256C91Q36273532-9866793A-390B-4EC9-9559-F8146F7A0900Q36447669-5B79665C-33CF-4B30-8EF6-29B6FEBE0CBEQ36706259-7E136FCD-3BA3-406E-92E1-E3078905DCBFQ37070125-4EC4B484-BBD9-44DA-A194-35E04376BC29Q37543908-58EAFAFC-57C7-486D-981F-A5826739CF3CQ37676008-BDDBBF4B-5A9E-44B8-A5F0-5FD97F680AA0Q37714428-70CC42AE-E7EC-4C6D-9E4F-E94E2C0E9656Q38588503-AB881608-F48B-4B75-96AC-F03B681D5862Q38603571-A6A3897C-5019-4678-BC7F-0DCF69124F62Q38716615-F8600BEF-036C-4174-88F9-8D3BF7E1CD72Q38730348-07D31FA2-58BB-4C78-89FD-7113144C3C8BQ38839110-F3CA7A20-453A-4D0D-8A62-2A87B8F0123BQ38853680-71B7A325-056B-4DBC-9680-F27278478CEAQ38860382-B23B2B55-5B05-4E43-AF05-E5FA3614A24FQ38873214-8EAF0268-91B9-488C-9185-2A6BF93B65FDQ38875474-B1C92CC2-360B-4B37-9A62-3574D19559DEQ38896940-58A3DDF5-763C-4186-B16C-F5F33A8F937DQ38919780-F79B958B-91B2-4ADA-A4A3-26CCC3F79121Q38936555-79442DA4-2857-40F3-B053-A4E12EE5C787Q38998423-1397C316-6B79-4166-B59D-E50E8DF380EEQ39048659-18FB1FA8-244C-4B8A-92E2-C3501B549099Q39093224-D80E4855-EC1A-408E-A0D2-F43B442FF5FAQ39189394-68430245-5C87-49F6-B0B7-F25C5462AF57Q39236676-A703A0A9-974C-48B7-AEF4-7CB445C9B0CAQ39569192-7A298706-0507-467D-92A6-18DB6D9CF153Q39834224-0C03245A-B97F-4ACB-84A9-0DC9986E55FBQ40385399-62A28F75-259C-45B3-8B8D-F095DD0A068CQ41716558-1004308E-0944-4612-B4DA-BAECFA7D91BAQ42219946-9EDBE462-7FBC-43D5-B7F9-95F14329FC2FQ42644178-3075A910-3BFF-46FD-A37D-1A83CAC42AE4Q42650181-142EE6DC-ACD5-4663-B1CB-7B6CA0E36553Q43176479-C661FCC0-469F-4B93-9E69-EA8715E38491Q47104071-E20F1162-460F-4BCE-AFC7-0F4130A87B40
P2860
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.
@en
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.
@nl
type
label
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.
@en
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.
@nl
prefLabel
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.
@en
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.
@en
P2093
Alberto Toso
Carlo Catapano
Erica Montani
Manuela Sarti
Mario Eisenberger
Sandra Pinton
Tanja Rezzonico Jost
P2860
P2888
P304
P356
10.1038/NATURE13638
P407
P50
P577
2014-08-24T00:00:00Z
P5875
P6179
1047010405